共 251 条
[1]
Hou PP(2020)Ectosomal PKM2 promotes HCC by inducing macrophage differentiation and remodeling the tumor microenvironment Mol Cell 78 1192-206.e10
[2]
Luo LJ(2006)Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature Ann Oncol 17 v153-v157
[3]
Chen HZ(2020)Phase Ib study of Lenvatinib plus Pembrolizumab in patients with Unresectable hepatocellular carcinoma J Clin Oncol 38 2960-2970
[4]
Chen QT(2017)Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial Lancet (London, England) 389 2492-2502
[5]
Bian XL(2020)Immuno-metabolism and microenvironment in Cancer: key players for immunotherapy Int J Mol Sci 21 4414-77.e22
[6]
Wu SF(2019)Integrated Proteogenomic characterization of HBV-related hepatocellular carcinoma Cell 179 561-8
[7]
Pastorelli D(2017)Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy J Immunother Cancer 5 44-45 e20
[8]
Cartei G(2014)Clinical significance of macrophage heterogeneity in human malignant tumors Cancer Sci 105 1-1380
[9]
Zustovich F(2019)Landscape and dynamics of single immune cells in hepatocellular carcinoma Cell 179 829-158
[10]
Marchese F(2021)M2 macrophage-derived exosomes facilitate HCC metastasis by transferring α(M) β(2) integrin to tumor cells Hepatology (Baltimore, Md) 73 1365-1592